OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Optimizerx Corporation.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.133 management during today's call. 00:00:03.276 -- 00:00:07.803 The company will also be discussing certain non-GAAP financial measures which it believes 00:00:07.803 -- 00:00:12.430 are useful in evaluating the company's operating results. 00:00:12.430 -- 00:00:17.638 A reconciliation of such non-GAAP financial measures is included in the earning release 00:00:17.638 -- 00:00:22.245 the company issued this afternoon as well as in the investor relations section of the 00:00:22.245 -- 00:00:24.308 company's website. 00:00:24.308 -- 00:00:28.676 I would like to remind everyone that today's call has been recorded and will be made 00:00:28.676 -- 00:00:33.824 available for replay as an audio recording of this conference call on the investor relations 00:00:33.824 -- 00:00:36.805 section of the company's website. 00:00:36.828 -- 00:00:42.096 I would now like to turn the conference over to OptimizeRx CEO, Steve 00:00:42.096 -- 00:00:46.740 Silvestro. Mr. Silvestro, please go ahead. 00:00:47.203 -- 00:00:51.530 Thank you, Operator, and good afternoon to everyone joining today's first quarter 2025 00:00:51.530 -- 00:00:56.595 call. I'm delighted to share our first quarter 2025 results, which came in ahead 00:00:56.595 -- 00:01:00.760 of both consensus estimates and our internal expectations. 00:01:00.760 -- 00:01:06.266 Momentum from Q4 has continued into 2025 with Q1 revenues increasing 11% 00:01:06.266 -- 00:01:11.951 year-over-year to $21.9 million, with adjusted EBITDA coming in at $1.5 million, 00:01:11.951 -- 00:01:16.376 an improvement of nearly $2 million year-over-year during what is typically our seasonally 00:01:16.376 -- 00:01:21.410 weakest quarter. Moreover, our contracted revenue continues to increase to more than 00:01:21.410 ...